Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids

被引:50
作者
Addla, Dinesh [1 ]
Jallapally, Anvesh [1 ]
Gurram, Divya [1 ]
Yogeeswari, Perumal [2 ]
Sriram, Dharmarajan [2 ]
Kantevari, Srinivas [1 ,3 ]
机构
[1] CSIR, Indian Inst Chem Technol, CPC Div, Organ Chem Div 2, Hyderabad 500007, Andhra Pradesh, India
[2] Birla Inst Technol & Sci Pilani, Pharm Grp, Med Chem & Antimycobacterial Res Lab, Hyderabad 500078, Andhra Pradesh, India
[3] CSIR, Indian Inst Chem Technol, Acad Sci & Innovat Res, Hyderabad 500007, Andhra Pradesh, India
关键词
Phenothiazine; Triazoles; Molecular hybridization; Antimycobacterial activity; Mycobacterium tuberculosis; MULTIDRUG-RESISTANT TUBERCULOSIS; MOLECULAR HYBRIDIZATION; PHENOTHIAZINES; DRUGS;
D O I
10.1016/j.bmcl.2013.11.031
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Molecular hybridization is an emerging structural modification tool to design molecules with better pharmacophoric properties. A series of novel 2-(trifluoromethyl)phenothiazine-1,2,3-triazoles 5a-v designed by hybridizing two antitubercular drugs trifluoperazine and I-A09 in a single molecular architecture, were synthesized in very good yields using click chemistry. Among the all '22' compounds screened for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv (Mtb), three analogs 5c, 5l and 5o were found to be most potent (MIC: 6.25 mu g/mL) antitubercular agents with good selectivity index. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 35 条
[1]   Tuberculosis 2013:5 Drug-resistant tuberculosis: time for visionary political leadership [J].
Abubakar, Ibrahim ;
Zignol, Matteo ;
Falzon, Dennis ;
Raviglione, Mario ;
Ditiu, Lucica ;
Masham, Susan ;
Adetifa, Lfedayo ;
Ford, Nathan ;
Cox, Helen ;
Lawn, Stephen D. ;
Marais, Ben J. ;
McHugh, Timothy D. ;
Mwaba, Peter ;
Bates, Matthew ;
Lipman, Marc ;
Zijenah, Lynn ;
Logan, Simon ;
McNerney, Ruth ;
Zumla, Adam ;
Sarda, Krishna ;
Nahid, Payam ;
Hoelscher, Michael ;
Pletschette, Michel ;
Memish, Ziad A. ;
Kim, Peter ;
Hafner, Richard ;
Cole, Stewart ;
Migliori, Giovanni Battista ;
Maeurer, Markus ;
Schito, Marco ;
Zumla, Alimuddin .
LANCET INFECTIOUS DISEASES, 2013, 13 (06) :529-539
[2]  
Agarwal P., 2013, INT J PHARM BIOMED R, V4, P114
[3]   Recent Developments in Antitubercular Drugs [J].
Ahirrao, Pallavi .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (14) :1441-1451
[4]   SYNERGIC EFFECT OF CHLORPROMAZINE ON THE ACTIVITY OF SOME ANTIBIOTICS [J].
AMARAL, L ;
KRISTIANSEN, J ;
LORIAN, V .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (04) :556-558
[5]   Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies [J].
Amaral, L ;
Kristiansen, JE .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (03) :173-176
[6]   Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis:: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy [J].
Amaral, L ;
Kristiansen, JE ;
Viveiros, M ;
Atouguia, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (05) :505-511
[7]  
[Anonymous], 2012, Global Tuberculosis Report
[8]  
Belei D., 2009, Acta Chem. Ias, V17, P197
[9]   A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis [J].
Dartois, Veronique ;
Barry, Clifton E., III .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) :4741-4750
[10]   Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination [J].
Diel, Roland ;
Loddenkemper, Robert ;
Zellweger, Jean-Pierre ;
Sotgiu, Giovanni ;
D'Ambrosio, Lia ;
Centis, Rosella ;
van der Werf, Marieke J. ;
Dara, Masoud ;
Detjen, Anne ;
Gondrie, Peter ;
Reichman, Lee ;
Blasi, Francesco ;
Migliori, Giovanni Battista .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) :785-801